ESC Premium Access

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Congress Session

About the speaker

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

9 more presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)

Thumbnail

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Stockholm, SE)

Thumbnail

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)

Thumbnail

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Access the full session

Anticoagulation in atrial fibrillation

Speakers: Doctor P. Noseworthy, Assistant Professor B. Hornestam, Associate Professor L. Friberg, Doctor P. Noseworthy, Mr J. Butt...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk